We also recommend that any patient presenting with isolated breast cancer not fulfilling the criteria presented in Table 3 and in whom a TP53 variant has been identified, should be referred to an expert genetics service that can interpret its true meaning and to a multi-disciplinary team for discussion [14]. This evidence concerns the gene TP53 and breast carcinoma.